Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cyclopenta(c)pyrrole-2(1h)-carboxamide, Hexahydro-n-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-(methyl-7h-pyrrolo(2,3-d)pyrimidin-4-ylamino)-, (3a Alpha,5 Alpha,6a Alpha)-
2. Ivarmacitinib Sulfate
3. Shr0302
4. Shr0302 Base
1. Shr0302
2. 1445987-21-2
3. Ivarmacitinib [usan]
4. Unii-k6k4b9z5tv
5. K6k4b9z5tv
6. (3as,6ar)-n-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-[methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrole-2-carboxamide
7. Shr-0302
8. Shr0302 Base
9. Ivarmacitinib [inn]
10. Shr0302 Free Base
11. Shr-0302 Free Base
12. Schembl15077696
13. Schembl15077710
14. Schembl16191633
15. Gtpl11878
16. Ex-a5101
17. Who 11823
18. Ncgc00687790-01
19. Ac-36766
20. Example 34 [wo2013091539a1]
21. Hy-112724
22. Cs-0062969
23. Us9527851, 34
24. Us9527851, 74
25. (3ar,5s,6as)-n-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-(methyl (7h-pyrrolo(2,3- D)pyrimidin-4-yl)amino) Hexahydrocyclopenta(c)pyrrole-2(1h)-carboxamide
26. (3ar,5s,6as)-n-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-(methyl (7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino) Hexahydrocyclopenta(c)pyrrole-2(1h)-carboxamide
27. (3ar,6as)-n-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-[methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrole-2-carboxamide
28. Cyclopenta(c)pyrrole-2(1h)-carboxamide, Hexahydro-n-(3-methoxy-1,2,4- Thiadiazol-5-yl)-5-(methyl-7h-pyrrolo(2,3-d)pyrimidin-4-ylamino)-, (3a.alpha.,5.alpha.,6a.alpha.)-
29. Cyclopenta(c)pyrrole-2(1h)-carboxamide, Hexahydro-n-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-(methyl-7h-pyrrolo(2,3-d)pyrimidin-4-ylamino)-, (3aalpha,5alpha,6aalpha)-
30. Rel-(3ar,5s,6as)-n-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-(methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)hexahydrocyclopenta[c]pyrrole-2(1h)-carboxamide
Molecular Weight | 414.5 g/mol |
---|---|
Molecular Formula | C18H22N8O2S |
XLogP3 | 2.3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 4 |
Exact Mass | 414.15864315 g/mol |
Monoisotopic Mass | 414.15864315 g/mol |
Topological Polar Surface Area | 140 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 600 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
54
PharmaCompass offers a list of SHR0302 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right SHR0302 manufacturer or SHR0302 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred SHR0302 manufacturer or SHR0302 supplier.
PharmaCompass also assists you with knowing the SHR0302 API Price utilized in the formulation of products. SHR0302 API Price is not always fixed or binding as the SHR0302 Price is obtained through a variety of data sources. The SHR0302 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A SHR0302 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of SHR0302, including repackagers and relabelers. The FDA regulates SHR0302 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. SHR0302 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A SHR0302 supplier is an individual or a company that provides SHR0302 active pharmaceutical ingredient (API) or SHR0302 finished formulations upon request. The SHR0302 suppliers may include SHR0302 API manufacturers, exporters, distributors and traders.
click here to find a list of SHR0302 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A SHR0302 DMF (Drug Master File) is a document detailing the whole manufacturing process of SHR0302 active pharmaceutical ingredient (API) in detail. Different forms of SHR0302 DMFs exist exist since differing nations have different regulations, such as SHR0302 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A SHR0302 DMF submitted to regulatory agencies in the US is known as a USDMF. SHR0302 USDMF includes data on SHR0302's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The SHR0302 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of SHR0302 suppliers with USDMF on PharmaCompass.
SHR0302 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of SHR0302 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right SHR0302 GMP manufacturer or SHR0302 GMP API supplier for your needs.
A SHR0302 CoA (Certificate of Analysis) is a formal document that attests to SHR0302's compliance with SHR0302 specifications and serves as a tool for batch-level quality control.
SHR0302 CoA mostly includes findings from lab analyses of a specific batch. For each SHR0302 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
SHR0302 may be tested according to a variety of international standards, such as European Pharmacopoeia (SHR0302 EP), SHR0302 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (SHR0302 USP).